Toradol is the brand name for ketorolac, a powerful nonsteroidal anti-inflammatory drug (NSAID) used for short‑term relief of moderate to severe acute pain, often after surgery or injury. Available as tablets and injectable forms, it works by blocking prostaglandins that drive inflammation and pain. Because Toradol carries risks such as stomach bleeding, kidney strain, and increased bleeding, it is prescribed at the lowest effective dose for the shortest possible time, typically no more than five days. This overview explains common uses, dosing, precautions, side effects, interactions, and safe storage, so you can discuss options confidently with your healthcare professional today.
Toradol (ketorolac) is a potent NSAID indicated for the short-term management of moderate to severe acute pain in adults, such as post-operative pain, injury-related pain, or acute musculoskeletal flare-ups when opioid-sparing alternatives are desired. Unlike everyday OTC pain relievers, Toradol is not for mild or chronic pain and is typically used when rapid, strong analgesia is needed.
It works by inhibiting cyclooxygenase (COX) enzymes that help produce prostaglandins—chemical messengers involved in inflammation and pain signaling. Because this prostaglandin blockade also protects the stomach lining and supports kidney blood flow, Toradol must be used cautiously and for the shortest possible duration, usually not exceeding five total days across all formulations (injection and tablets combined).
Dosing must be individualized, using the lowest effective dose for the briefest time. Adults under 65 years without kidney impairment may receive a single IV dose of 30 mg or IM dose of 60 mg, or 15–30 mg IV/IM every 6 hours as needed, not to exceed 120 mg/day. Adults 65 and older, those with renal impairment, or patients under 50 kg typically receive reduced doses (for example, 15 mg IV/IM every 6 hours, maximum 60 mg/day). Your clinician will tailor the regimen based on pain severity, age, weight, kidney function, and other risks.
For oral use following parenteral therapy, a typical regimen starts with 10 mg, then 10 mg every 4–6 hours as needed, not exceeding 40 mg/day. Importantly, the combined duration of IV/IM and oral Toradol must not exceed five days due to the risk of gastrointestinal bleeding, kidney injury, and other adverse effects. Toradol should not be taken with other NSAIDs (e.g., ibuprofen, naproxen, aspirin used for pain) because this increases toxicity without improving pain control.
Take tablets with food or milk to reduce stomach upset, and drink adequate fluids unless your clinician advises otherwise. Never exceed the prescribed dose or duration, and contact your healthcare professional if pain persists or worsens—this medicine is designed as a short-term bridge, not a long-term solution.
Serious risks include gastrointestinal ulceration and bleeding, kidney dysfunction, elevated blood pressure, fluid retention, and heightened bleeding risk. These risks are higher in older adults, smokers, those with a history of ulcers or GI bleeding, kidney disease, dehydration, heart failure, uncontrolled hypertension, or those taking anticoagulants or antiplatelet drugs. Discuss your full medical history and medication list with your clinician before starting Toradol.
Pregnancy and labor/delivery: Like other NSAIDs, ketorolac can cause fetal harm, particularly in the third trimester (risk of premature closure of the ductus arteriosus) and is contraindicated during labor and delivery due to bleeding risks and possible effects on uterine contractions. Breastfeeding requires individualized assessment; ketorolac can appear in breast milk, and alternatives may be preferred. Use caution with activities requiring alertness—dizziness or drowsiness can occur, especially with injectable dosing or when combined with alcohol or sedating medicines.
Toradol is contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding or perforation, a history of severe NSAID or aspirin allergy (including bronchospasm, anaphylaxis, or angioedema), advanced renal impairment, or those at high risk of bleeding. It is also contraindicated for use during coronary artery bypass graft (CABG) surgery and during labor and delivery.
Concomitant use with probenecid or pentoxifylline is contraindicated due to significantly increased ketorolac levels and bleeding risk. Intrathecal or epidural administration is contraindicated. Pediatric safety and efficacy for standard indications are not established in many settings; follow specialist guidance if considered off-label.
Common side effects include dyspepsia, abdominal pain, nausea, vomiting, diarrhea, dizziness, headache, drowsiness, and injection-site discomfort with IM use. These typically improve as the drug is tapered and stopped within the five-day limit. Taking tablets with food and avoiding alcohol may reduce stomach upset.
Serious adverse effects can include gastrointestinal ulceration or bleeding (manifesting as black stools, vomiting blood, severe stomach pain), kidney problems (reduced urine output, swelling, fatigue), increased blood pressure, fluid retention, and serious skin reactions or hypersensitivity (rash, hives, wheezing, facial or throat swelling). Toradol increases bleeding tendency because it affects platelet function; report unusual bruising, bleeding gums, or prolonged bleeding.
Seek emergency care for signs of anaphylaxis, chest pain, shortness of breath, sudden weakness on one side of the body, severe headache, or signs of GI bleeding. Because the risk profile escalates with dose and duration, adherence to the prescribed regimen is essential.
Avoid combining Toradol with other NSAIDs (ibuprofen, naproxen, high-dose aspirin for pain) due to additive gastrointestinal and renal toxicity. Concurrent use with anticoagulants (warfarin, apixaban, rivaroxaban), antiplatelets (aspirin, clopidogrel), and certain antidepressants (SSRIs/SNRIs) can raise bleeding risk. If low-dose aspirin is prescribed for cardiovascular protection, your clinician will help weigh risks and timing.
ACE inhibitors, ARBs, and diuretics used together with ketorolac can impair kidney function, especially in dehydrated or older patients. Ketorolac can increase lithium levels and toxicity; careful monitoring or alternative analgesics may be necessary. Methotrexate clearance may be reduced, heightening toxicity risk. Corticosteroids and heavy alcohol use further increase GI bleeding risk. Probenecid and pentoxifylline are contraindicated due to major pharmacokinetic and bleeding interactions.
Always provide a comprehensive medication list, including over-the-counter pain relievers, herbal supplements (e.g., ginkgo, garlic, ginseng), and topical NSAIDs, so your clinician can mitigate interaction risks and tailor your pain management plan.
If you’re using oral Toradol on a scheduled basis and miss a dose, take it when remembered unless it’s near the time for the next dose—if so, skip the missed dose. Do not double up. Many patients receive Toradol as needed or via injection in a clinical setting, in which case the care team will guide timing. Always follow your prescriber’s instructions.
Overdose may cause severe stomach pain, vomiting, drowsiness, dizziness, gastrointestinal bleeding, kidney impairment, or metabolic acidosis. There is no specific antidote. If an overdose is suspected, call emergency services or poison control immediately. Early administration of activated charcoal may be considered by clinicians if presentation is soon after ingestion; otherwise, management is supportive, with monitoring of vitals, renal function, and bleeding.
Do not attempt to treat serious pain by taking extra Toradol or combining it with other NSAIDs. If pain is uncontrolled, seek medical evaluation to reassess your regimen and identify safer alternatives.
Store Toradol tablets at room temperature (generally 20–25°C/68–77°F), protected from moisture and excessive heat. Keep injectable solutions as directed by the manufacturer or healthcare facility, avoiding freezing and protecting from light if specified. Always keep medications in their original containers and out of reach of children and pets. Safely discard unused or expired Toradol according to local take-back programs.
In the United States, Toradol (ketorolac) is a prescription-only medicine due to its potency and risk profile. It should be used under the supervision of a licensed clinician, and pharmacies dispense it only with a valid prescription. Buying Toradol without a prescription is not legal, and unregulated sources (especially online) pose significant safety risks, including counterfeit or substandard products and lack of professional oversight.
If you need timely pain assessment, integrated health systems and rehabilitation networks—such as organizations affiliated with Geisinger—offer legitimate, structured access to care through in-person clinics, urgent care, or telehealth visits. During a proper medical evaluation, a clinician can determine whether Toradol is appropriate and, if so, provide a prescription to be filled at a licensed pharmacy.
Bottom line: there is no lawful pathway to obtain Toradol without a prescription in the U.S. For safe, effective pain relief, seek evaluation from a qualified healthcare professional who can tailor therapy, discuss alternatives, and monitor for side effects and drug interactions.
Toradol, the brand name for ketorolac, is a nonsteroidal anti-inflammatory drug (NSAID) used for short-term treatment of moderately severe acute pain that often requires opioid-level relief, such as after surgery, injury, or kidney stones. It is not for minor aches or for chronic conditions.
Ketorolac blocks cyclooxygenase (COX-1 and COX-2) enzymes that make prostaglandins—chemical messengers that drive pain, inflammation, and fever. By lowering prostaglandins, it eases pain and reduces inflammatory swelling.
When given IV, pain relief can begin within 30 minutes, with peak effect around 1 to 2 hours. IM and nasal spray act similarly fast. Oral tablets have a slightly slower onset. Analgesia typically lasts 4 to 6 hours.
Toradol comes as IV or IM injection, a nasal spray, and oral tablets. Hospitals often start with IV/IM or nasal spray for rapid relief, then switch to oral tablets to complete therapy. Oral tablets are intended only as a continuation after an injection, not as the first dose.
Typical adult dosing depends on age, kidney function, and weight. Younger, healthy adults may receive higher doses than older adults or those with renal impairment or low body weight. The key rule: do not exceed a total of 5 days of combined therapy for all forms due to safety risks. Your clinician will tailor the exact dose and interval.
Prolonged use markedly increases the risk of serious stomach or intestinal bleeding, kidney injury, and cardiovascular complications. The 5-day cap balances potent pain relief with a reduced risk of harm.
Avoid Toradol if you have active peptic ulcers or recent GI bleeding, advanced kidney disease, a history of aspirin/NSAID-induced asthma or severe allergic reactions, bleeding disorders, are on probenecid or pentoxifylline, are undergoing coronary artery bypass graft (CABG) surgery, are in labor or late pregnancy, or have a high bleeding risk. It is not approved for pediatric use in many regions.
Common effects include stomach upset, nausea, indigestion, headache, dizziness, drowsiness, fluid retention, and injection-site discomfort. Many are mild and temporary but monitor for worsening symptoms.
Seek urgent care for black or bloody stools, vomiting blood, severe stomach pain, sudden weakness or slurred speech (possible stroke), chest pain or shortness of breath (heart risk), decreased urine output or swelling (kidney injury), severe rash or facial swelling (allergy), or unusual bruising/bleeding.
No. Do not combine Toradol with other NSAIDs (ibuprofen, naproxen, diclofenac, indomethacin, meloxicam) or high-dose aspirin. Doing so greatly increases the risk of GI bleeding and kidney problems. Low-dose aspirin for cardiovascular protection may still raise bleeding risk—discuss carefully with your prescriber.
Avoid Toradol in the third trimester due to risks like premature closure of the fetal ductus arteriosus. It is generally avoided after 20 weeks because it can impair fetal kidneys and reduce amniotic fluid. It is not recommended while breastfeeding, especially with repeated dosing; discuss safer alternatives with your clinician.
Older adults are more prone to stomach bleeding, kidney injury, and cardiovascular events. If used, lower doses and the shortest possible duration (never beyond 5 days) are critical, with close monitoring and consideration of gastroprotection.
No. Toradol is an NSAID, not an opioid. It does not cause euphoria and is not a controlled drug. However, misuse can still cause serious harm.
Ketorolac can reduce blood flow to the kidneys, potentially triggering acute kidney injury, especially in dehydration, heart failure, or existing renal disease. It can also raise blood pressure or blunt the effect of antihypertensives. Adequate hydration and monitoring are important.
High-risk interactions include anticoagulants (warfarin, DOACs), antiplatelets (clopidogrel), other NSAIDs and steroids (GI bleed risk), SSRIs/SNRIs (bleeding risk), lithium and methotrexate (toxicity), ACE inhibitors/ARBs and diuretics (kidney injury), probenecid (contraindicated; raises ketorolac levels), and pentoxifylline (contraindicated; bleeding). Always review your medication list with your clinician.
It’s best to avoid alcohol. Alcohol increases the chance of stomach irritation and bleeding with NSAIDs, including Toradol.
Yes. Clinicians commonly use IV/IM or nasal ketorolac for acute migraine in emergency settings, renal colic, and after surgery as an opioid-sparing strategy. Appropriateness depends on your risks and procedure type.
Share any history of ulcers or GI bleeding, kidney or heart disease, stroke, asthma, bleeding disorders, high blood pressure, pregnancy or trying to conceive, all current medications and supplements, and alcohol use. Mention any previous reactions to NSAIDs.
Take the missed dose when remembered unless it’s near time for the next dose. Do not double up. Never extend use beyond the prescribed 5-day total.
Store tablets and nasal spray at room temperature, away from moisture and heat, and out of children’s reach. Injections are stored and administered by healthcare professionals.
Toradol is generally more potent and fast-acting, especially by injection, and is typically reserved for acute, moderate to severe pain in clinical settings. Ibuprofen is effective for mild to moderate pain and inflammation and is suitable for over-the-counter or longer-term use when appropriate. Toradol carries a higher risk of GI and renal adverse events and must be limited to 5 days.
Naproxen has a longer half-life and is better for sustained pain control over the day in chronic or subacute conditions. Toradol provides strong, short-term relief with strict duration limits and higher bleeding risk, best for brief acute episodes under supervision.
Both are effective NSAIDs. Toradol is often chosen for short-term, opioid-sparing postoperative or emergency pain via injection or nasal spray. Diclofenac is widely used for musculoskeletal pain, arthritis, and localized conditions (including topical gel) and can be used longer term if appropriate. Toradol’s GI and renal risk profile necessitates stricter limits.
Both can help renal colic; Toradol injections offer rapid relief in ER settings. For gout flares, indomethacin has a long history of use but can be hard to tolerate; Toradol can be used short term for severe pain. Both raise GI and renal risks; choice depends on route needed, tolerance, and comorbidities.
Meloxicam is a once-daily NSAID often used chronically for osteoarthritis or rheumatoid arthritis with somewhat improved GI tolerability at lower doses. Toradol is intended only for short-term, acute, higher-intensity pain with a 5-day maximum and is not for chronic use.
Celecoxib is COX-2 selective and tends to cause fewer GI ulcers than nonselective NSAIDs like ketorolac, though bleeding risk is not zero. Toradol carries a higher GI bleeding risk and is limited to short-term use. Celecoxib may carry cardiovascular risks; patient-specific factors guide the choice.
Do not combine Toradol with aspirin used for pain or inflammation. Low-dose aspirin for heart protection can still increase bleeding risk if taken with Toradol; this combination requires careful medical oversight, and gastroprotection may be considered.
Toradol injection generally provides faster and stronger pain relief than oral ibuprofen due to parenteral administration and potency. Oral ibuprofen is slower and milder but safer for home use and longer durations when appropriate.
Toradol is typically more potent for acute moderate to severe pain and is available in injectable and nasal forms for rapid relief. Ketoprofen (where available) is used for mild to moderate pain and inflammation and for chronic conditions; it lacks the same parenteral options in many regions.
Etodolac may offer somewhat improved GI tolerability for chronic musculoskeletal pain compared with some NSAIDs and is used longer term when needed. Toradol is reserved for brief, intense pain episodes with a higher GI risk and a strict 5-day maximum.
Piroxicam has a very long half-life and is used for chronic arthritic conditions but carries significant GI risk, especially with prolonged use. Toradol is not for chronic therapy and should only be used short term for acute pain crises.
Both are used in hospitals as opioid-sparing analgesics. Toradol often provides comparable or greater pain relief per dose but has a higher GI bleeding and renal risk profile and a 5-day maximum. IV ibuprofen can be used for postoperative pain and fever with more flexible duration but still carries NSAID risks.
Topical diclofenac targets localized musculoskeletal pain with much lower systemic exposure and fewer GI/renal risks. Toradol is systemic and used for short-term relief of more severe, generalized acute pain. For isolated joint or tendon pain, topical therapy is often safer.